Increased L-arginine uptake and inducible nitric oxide synthase activity in aortas of rats with heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 280, Issue 2 49-2, 2001, Pages

  Stathopulos, Peter B ^a   Lu, Xiangru ^a   Shen, Ji ^a   Scott, Jeremy A ^a   Hammond, James R ^a   Mccormack, David G ^a   Arnold, J Malcolm O ^a   Feng, Qingping ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Cationic amino acid transporter; Myocardial dysfunction; Vascular biology

Indexed keywords

AMINO ACID TRANSPORTER 2B; ARGININE; ARGININE METHYL ESTER; CARRIER PROTEIN; DEXTRO ARGININE; LYSINE; NITRATE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG UPTAKE; ENZYME ACTIVITY; HEART FAILURE; HEART INFARCTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0035000099     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.280.2.h859     Document Type: Article

References (30)

1. Abbott RE and Schachter D. Regional differentiation in rat aorta: L-arginine metabolism and cGMP content in vitro. Am J Physiol Heart Circ Physiol 266: H2287-H2295, 1994.
2. Bogle RG, Moncada S, Pearson JD, and Mann GE. Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter. Br J Pharmacol 105: 768-770, 1992.
3. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
4. Chen LY and Mehta JL. Evidence for the presence of L-arginine-nitric oxide pathway in human red blood cells: relevance in the effects of red blood cells on platelet function. J Cardiovasc Pharmacol 32: 57-61, 1998.
5. Christensen HN. Role of amino acid transport and counter-transport in nutrition and metabolism. Physiol Rev 70: 43-77, 1990.
6. Closs EI, Lyons CR, Kelly C, and Cunningham JM. Characterization of the third member of the MCAT family of cationic amino acid transporters. Identification of a domain that determines the transport properties of the MCAT proteins. J Biol Chem 268: 20796-20800, 1993.
7. Drexler H and Lu W. Endothelial dysfunction of hindquarter resistance vessels in experimental heart failure. Am J Physiol Heart Circ Physiol 262: H1640-H1645, 1992.
8. Feng Q, Fortin AJ, Lu X, and Arnold JMO. Effects of L-arginine on endothelial and cardiac function in rats with heart failure. Eur J Pharmacol 376: 37-44, 1999.
9. Feng Q, Lu XR, Fortin AJ, Pettersson A, Hedner T, Kline RL, and Arnold JMO. Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure. Cardiovasc Res 37: 667-675, 1998.
10. Fukuchi M, Hussain SNA, and Giaid A. Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure. Circulation 98: 132-139, 1998.
11. Gill DJ, Low B, and Grigor MR. Interleukin-1b and tumor necrosis factor-a stimulate the CAT-2 gene of the L-arginine transporter in cultured vascular smooth muscle cells. J Biol Chem 271: 11280-11283, 1996.
12. Greene B, Pacitti AJ, and Souba WW. Characterization of L-arginine transport by pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 264: L351-L356, 1993.
13. Habib F, Dutka D, Crossman D, Oakley CM, and Cleland JG. Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism? Lancet 344: 371-373, 1994.
14. Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, and Polak JM. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 347: 1151-1155, 1996.
15. Hanssen H, Brunini TM, Conway M, Banning AP, Roberts NB, Mann GE, Ellory JC, and Mendes Ribeiro AC. Increased L-arginine transport in human erythrocytes in chronic heart failure. Clin Sci (Lond) 94: 43-48, 1998.
16. Haywood GA, Tsao PS, Von LHE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, McKenna WJ, and Fowler MB. Expression of inducible nitric oxide synthase in human heart failure. Circulation 93: 1087-1094, 1996.
17. Ikeda U, Murakami Y, Kanbe T, and Shimada K. Alpha-adrenergic stimulation enhances inducible nitric oxide synthase expression in rat cardiac myocytes. J Mol Cell Cardiol 28: 1539-1545, 1996.
18. Irwin MW, Mak S, Mann DL, Qu R, Penninger JM, Yan A, Dawood F, Wen WH, Shou Z, and Liu P. Tissue expression and immunolocalization of tumor necrosis factor-a in postinfarction dysfunctional myocardium. Circulation 99: 1492-1498, 1999.
19. Kim JW, Closs EI, Albritton LM, and Cunningham JM. Transport of cationic amino acids by the mouse ecotropic retrovirus receptor. Nature 352: 725-728, 1991.
20. Kiuchi K, Sato N, Shannon RP, Vatner DE, Morgan K, and Vatner SF. Decreased β-adrenergic receptor- and endothelium-mediated vasodilation in conscious dogs with heart failure. Circ Res 73: 1013-1023, 1993.
21. Levine B, Kalman J, Mayer L, Fillit HM, and Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323: 236-241, 1990.
22. Low BC and Grigor MR. Angiotensin II stimulates system y-and cationic amino acid transporter gene expression in cultured vascular smooth muscle cells. J Biol Chem 270: 27577-27583, 1995.
23. Moncada S, Palmer RM, and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
24. Oddis CV, Simmons RL, Hattler BG, and Finkel MS. cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes. Am J Physiol Heart Circ Physiol 269: H2044-H2050, 1995.
25. Scott JA, Machoun M, and McCormack DG. Inducible nitric oxide synthase and vascular reactivity in rat thoracic aorta: effect of aminoguanidine. J Appl Physiol 80: 271-277, 1996.
26. Simmons WW, Closs EI, Cunningham JM, Smith TW, and Kelly RA. Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes. Regulation of L-arginine transport and no production by CAT-1, CAT-2A, and CAT-2B. J Biol Chem 271: 11694-11702, 1996.
27. Song W, Lu X, and Feng Q. Tumor necrosis factor-α induces apoptosis in cardiac myocytes via inducible nitric oxide synthase. Cardiovasc Res 45: 595-602, 2000.
28. Wang BY, Ho HK, Lin PS, Schwarzacher SP, Pollman MJ, Gibbons GH, Tsao PS, and Cooke JP. Regression of atherosclerosis: role of nitric oxide and apoptosis. Circulation 99: 1236-1241, 1999.
29. Wang H, Kavanauhg MP, North RA, and Kabat D. Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter. Nature 352: 729-731, 1991.
30. Wong H, Anderson WD, Cheng T, and Riabowol KT. Monitoring mRNA expression by polymerase chain reaction: the "primer-dropping" method. Anal Biochem 223: 251-258, 1994.